Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12804606 | 0.89 | ALDH1A1 (0.47) | ALDH1A1TSHRSMN1; SMN2TDP1MAPK1 | |
| SCHEMBL21055880 | 0.86 | ALDH1A1 (0.59) | ALDH1A1TSHRSMN1; SMN2TDP1MAPK1 | |
| SCHEMBL1127982 | 0.84 | TSHR (0.61) | ALDH1A1TSHRSMN1; SMN2TDP1MAPK1 | |
| SCHEMBL49884 | 0.84 | TSHR (0.61) | ALDH1A1TSHRSMN1; SMN2TDP1MAPK1 | |
| SCHEMBL13810709 | 0.84 | — | — | |
| SCHEMBL15268272 | 0.84 | TSHR (0.61) | ALDH1A1TSHRSMN1; SMN2TDP1MAPK1 | |
| SCHEMBL4313163 | 0.84 | TSHR (0.61) | ALDH1A1TSHRSMN1; SMN2TDP1MAPK1 | |
| SCHEMBL15383241 | 0.84 | — | — | |
| SCHEMBL12481795 | 0.84 | TSHR (0.61) | ALDH1A1TSHRSMN1; SMN2TDP1MAPK1 | |
| SCHEMBL15033887 | 0.84 | TSHR (0.61) | ALDH1A1TSHRSMN1; SMN2TDP1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10752714-B2 | Resin composition | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2020-08-25 | — | — | US | disclosed |
| US-20190271929-A1 | LIQUID DEVELOPER AND METHOD FOR MANUFACTURING LIQUID DEVELOPER | CANON KABUSHIKI KAISHA (JP) | 2019-09-05 | — | — | US | disclosed |
| EP-3176216-B1 | HYDROPHILIC MATERIAL COMPRISING SULFONATE COPOLYMER AND AMINO RESIN | MITSUI CHEMICALS INC (JP) | 2019-04-24 | — | — | EP | disclosed |
| US-10175597-B2 | Liquid developer and method of producing same | CANON KABUSHIKI KAISHA (JP) | 2019-01-08 | — | — | US | disclosed |
| US-20180210362-A1 | METHOD OF PRODUCING CURABLE LIQUID DEVELOPER AND CURABLE LIQUID DEVELOPER | CANON KK (JP) | 2018-07-26 | — | — | US | disclosed |
| US-20180210362-A1 | METHOD OF PRODUCING CURABLE LIQUID DEVELOPER AND CURABLE LIQUID DEVELOPER | CANON KK (JP) | 2018-07-26 | — | — | US | disclosed |
| US-9976050-B2 | Hydrophilic materials including sulfonate copolymer and amino resin | MITSUI CHEMICALS, INC. (JP) | 2018-05-22 | — | — | US | disclosed |
| US-9971268-B2 | Curable liquid developer having a cationically polymerizable liquid monomer with a monofunctional vinyl ether compound | CANON KABUSHIKI KAISHA (JP) | 2018-05-15 | — | — | US | disclosed |
| US-9971268-B2 | Curable liquid developer having a cationically polymerizable liquid monomer with a monofunctional vinyl ether compound | CANON KABUSHIKI KAISHA (JP) | 2018-05-15 | — | — | US | disclosed |
| US-20180059566-A1 | UV-CURABLE LIQUID DEVELOPER, FIXING METHOD, IMAGE FORMING METHOD, AND UV-CURABLE COMPOSITION | CANON KABUSHIKI KAISHA (JP) | 2018-03-01 | — | — | US | disclosed |
| EP-2985301-A1 | COPOLYMER AND HYDROPHILIC MATERIAL COMPRISING SAME | Mitsui Chemicals, Inc. (JP) | 2016-02-17 | — | — | EP | disclosed |
| US-20160032036-A1 | COPOLYMER AND HYDROPHILIC MATERIAL COMPOSED OF THE SAME | MITSUI CHEMICALS, INC. (JP) | 2016-02-04 | — | — | US | disclosed |
| US-20150338556-A1 | NON-PHOTOSENSITIVE RESIN COMPOSITION | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2015-11-26 | — | — | US | disclosed |
| US-20150338556-A1 | NON-PHOTOSENSITIVE RESIN COMPOSITION | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2015-11-26 | — | — | US | disclosed |
| US-20150192875-A1 | ULTRAVIOLET-CURABLE LIQUID DEVELOPER | CANON KABUSHIKI KAISHA (JP) | 2015-07-09 | — | — | US | disclosed |
| US-20150192875-A1 | ULTRAVIOLET-CURABLE LIQUID DEVELOPER | CANON KABUSHIKI KAISHA (JP) | 2015-07-09 | — | — | US | disclosed |
| US-20140256870-A1 | COMPOSITION AND FILM COMPRISING SAME | MITSUI CHEMICALS, INC. (JP) | 2014-09-11 | — | — | US | disclosed |
| EP-2767552-A1 | COMPOSITION AND FILM COMPRISING SAME | Mitsui Chemicals, Inc. (JP) | 2014-08-20 | — | — | EP | disclosed |
| US-6887737-B1 | Epoxidized acetals and thioacetals, episulfidized acetals and thioacetals, and reworkable thermosetting resin compositions formulated therefrom | HENKEL CORPORATION (US) | 2005-05-03 | — | — | US | disclosed |
| WO-2003051955-A1 | EPOXIDIZED ACETALS AND THIOACETALS, EPISULFIDIZED ACETALS AND THIOACETALS, AND REWORKABLE THERMOSETTING RESIN COMPOSITIONS FORMULATED THEREFROM | HENKEL CORPORATION (US) | 2003-06-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10175597-B2 | Liquid developer and method of producing same | AUP1, RCC1, CBR1 | ALDH1A1 1142/4885TSHR 1523/4885SMN1; SMN2 1297/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.